Odyssey Therapeutics, Inc. ODTX NASDAQ · Healthcare · United States
$16.96 -7.52% -$1.38
Summary
45 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $80.6M against $23.5M.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapIs it growing?
Revenue (USD)
- Analyst estimate
For the next fiscal year analysts expect revenue to grow by 0.0%.
Growth in detailDoes it make money?
Over the last 12 months it made a loss of $177.6M.
Profitability in detailIs it financially healthy?
YesOver the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 2
- Hold 0
- Sell 0
Today's price within the analysts' price targets
The average target of $36.6 is 116% above today's price. 100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.